Resecurity, Braly Insurance partner to strengthen cyber risk management
The partnership will combine Resecurity's capabilities in identifying cyber threats with Braly's experience in risk management to facilitate a 'data-driven' approach to help companies mitigate cyber risks.
Resecurity CEO Gene Yoo said: 'We are excited to work with Braly Insurance Group because they truly understand the business impact of cybersecurity.
'This partnership opens the door to more productive conversations between security teams, business leaders, and insurers. It is about building a bridge between technical excellence and financial decision making.'
As part of the agreement, Braly will provide Resecurity with industry data and feedback from the market and help the company make connections within the insurance sector.
Braly Insurance Group business development vice-president Caden Braly stated: 'This partnership allows us to take a more sophisticated approach to cyber risk by integrating real-world security insights into our client advisory and placement process. It is a strategic step toward offering smarter, more adaptive risk solutions.'
Texas-based Braly operates across the US and internationally, providing services in areas such as property and casualty, employee benefits and financial services.
Founded in 2016, Resecurity offers a platform that integrates endpoint protection, risk management and threat intelligence.
This month, the company expanded its presence to Brazil, speeding up compliance with the Brazilian General Data Protection Law, while improving cyber resilience across the region.
"Resecurity, Braly Insurance partner to strengthen cyber risk management " was originally created and published by Life Insurance International, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 minutes ago
- Yahoo
Solesence Inc (SLSN) Q2 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Uplisting
Release Date: July 31, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Solesence Inc (NASDAQ:SLSN) reported a strong second quarter with a 56% year-over-year increase in revenue, reaching $20.4 million. The company successfully uplisted its common shares on NASDAQ, enhancing visibility and liquidity. Gross profit increased by 55% to $5.9 million, with gross margins expanding by 6 percentage points from the first quarter of 2025. Solesence Inc (NASDAQ:SLSN) showcased new product advancements at the Cosmerrof North America trade show, highlighting their innovation in the beauty industry. The company improved operational efficiencies and restructured debt facilities, increasing borrowing capacity to support growth initiatives. Negative Points Solesence Inc (NASDAQ:SLSN) anticipates a slowdown in demand in the second half of 2025 due to tariffs affecting global purchasing decisions. The company expects a muted impact on packaging component costs, which could affect margins. There is an uncertain tariff environment that may impact the company's top line in the latter half of the year. Despite improvements, the company faced challenges with production startup costs related to a new product line launch. Solesence Inc (NASDAQ:SLSN) is still in the process of searching for a new Chief Financial Officer, which may impact financial strategy execution. Q & A Highlights Warning! GuruFocus has detected 4 Warning Signs with SLSN. Q: Can you provide more details on how profit margins might improve over the year given the recent scaling and cost challenges? A: Jess Jankowski, President and CEO, explained that after overcoming initial challenges in Q1, the company has optimized production processes, leading to improved efficiencies. Kevin Curriton, COO, added that they have enhanced line utilization and labor efficiency, which should result in better gross profit margins in the coming quarters. Q: How did Solesence manage to achieve record revenues and unit volume shipped in Q2? A: Kevin Curriton, COO, attributed the success to ramping up inventory production early in the year to meet increased customer orders. The company also improved manufacturing execution, which led to a 102% increase in shipment volume and a 127% increase in production volume compared to the previous year. Q: What impact do you anticipate from the macroeconomic environment on Solesence's performance in the second half of 2025? A: Kevin Curriton, COO, noted that while the company is well-diversified, they expect demand to slow due to tariffs affecting global purchasing decisions. However, they still project a record revenue year and plan to pass new tariff expenses through without affecting margins. Q: Can you elaborate on the financial flexibility enhancements mentioned during the call? A: Kevin Curriton, COO, stated that Solesence amended its loan agreements to increase borrowing capacity from $14.2 million to $23 million, extending maturities to April 2027. This financial flexibility supports growth initiatives, raw material procurement, and product launches. Q: What are the key reasons for Solesence's confidence in its long-term prospects despite expected market challenges? A: Jess Jankowski, President and CEO, highlighted three reasons: leveraging patented technology and specialized formulations, a strong roster of loyal brand customers ensuring recurring revenue, and improved operational and financial flexibility to invest and scale for growth. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 minutes ago
- Yahoo
Novo Nordisk shares hit 4-year low, Trump urges US drug price cuts
(Reuters) -Shares in Wegovy maker Novo Nordisk fell around 4% on Friday to their lowest since August 2021, after U.S. President Donald Trump sent letters to major pharmaceutical firms to cut drug prices in the United States. Friday's drop brings this week's losses for Novo to more than 30% - marking its worst-ever weekly fall - after it slashed its outlook for 2025 sales growth and appointed veteran insider Maziar Mike Doustdar as its new CEO. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
4 minutes ago
- Yahoo
Carpenter Technology Corp (CRS) Q4 2025 Earnings Call Highlights: Record Operating Income and ...
Adjusted Operating Income: $151 million, a 21% increase year-over-year and a 10% increase sequentially. SAO Segment Operating Margin: 30.5%, up from 25.2% a year ago. SAO Segment Operating Income: $167 million, a 19% increase year-over-year. Adjusted Free Cash Flow: $201.3 million for the quarter. Share Repurchases: $24.1 million in the quarter, totaling $101.9 million for the fiscal year. Sales Growth: Aerospace and Defense sales up 3% sequentially; Medical sales up 6% sequentially; Energy sales up 27% sequentially. Gross Profit: $213.9 million, up 12% year-over-year. SG&A Expenses: $62.5 million, flat sequentially. Effective Tax Rate: 19.7% for the quarter. Earnings Per Diluted Share: $2.21 for the quarter. Cash from Operating Activities: $258 million for the quarter. Capital Expenditures: $58 million for the quarter, $154.3 million for the fiscal year. Total Liquidity: $664.4 million, including $315.5 million in cash. Net Debt-to-EBITDA Ratio: 0.5x. Fiscal Year 2026 Operating Income Projection: $660 million to $700 million. Fiscal Year 2026 Adjusted Free Cash Flow Projection: $240 million to $280 million. Warning! GuruFocus has detected 8 Warning Signs with XYL. Release Date: July 31, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Carpenter Technology Corp (NYSE:CRS) achieved a record quarterly operating income of $151 million, marking a 21% increase over the previous year. The SAO segment reached a record operating income of $167 million, with operating margins expanding to 30.5%. The company generated $201.3 million in adjusted free cash flow during the quarter, demonstrating strong cash generation capabilities. Sales increased sequentially across all key end-use markets, with notable growth in the Aerospace and Defense, Medical, and Energy sectors. Carpenter Technology Corp (NYSE:CRS) completed several long-term agreements at the Paris Air Show, supporting ongoing growth in the Aerospace and Defense market. Negative Points Sales excluding surcharge decreased 2% year-over-year due to a 14% decline in volumes. The Medical end-use market saw a 16% decline in sales compared to the previous year's record fourth quarter. The PEP segment's net sales were down 5% from the same quarter a year ago, indicating challenges in this segment. The company anticipates planned maintenance activities in the upcoming quarter, which may impact operating income. There are concerns about inventory levels in the aerospace supply chain, particularly related to Boeing's 737 production. Q & A Highlights Q: Could you discuss the current lead times in jet engine and fasteners markets, and your expectations for pricing over the next few years? A: Tony Thene, CEO: Lead times remain extended, particularly in jet engines, and we expect them to stay that way. Pricing actions continue to be a tailwind for us, and we don't foresee any significant impact from competitors' capacity expansions. The supply-demand gap is large, and smaller investments by others are complementary, helping the industry build at a higher rate. Q: Did you approach the fiscal 2026 EBIT guidance with the same level of conservatism as the fiscal 2025 guidance? A: Tony Thene, CEO: We take our targets seriously and ensure we have a line of sight to achieve them. The market is more defined now than in May 2023, and we are confident in our ability to meet the fiscal 2026 guidance. Q: Are you seeing orders or conversations that support a reacceleration in Aerospace and Defense volumes? A: Tony Thene, CEO: Yes, particularly in defense, where demand is aggressive. In aerospace, there are two sub-groups: those tied to Boeing's 737, who may have more inventory, and those with broader offerings, who are pulling aggressively. Our bookings are up 17% to 18% sequentially, indicating positive momentum. Q: Can you frame the urgent requests from defense versus regular orders, and what does this look like over the medium term? A: Tony Thene, CEO: Defense orders are historically more uneven due to program specifics and budget dependencies. However, with clarity in the defense budget, we expect elevated order levels to continue. Q: How does your preventive maintenance strategy contribute to your long-term margin profile? A: Tony Thene, CEO: Preventive maintenance is crucial for asset availability and profitability. We use AI tools for predictive maintenance, keeping outages shorter and more targeted, which avoids long ramp-ups and maintains high operational levels. This is a strategic advantage for us. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
